“fsa eligible”的搜索结果，显示 111-120 项，共有 2537 项

1. 血液科- 临床试验- 妙佑医疗国际

   Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Immune ...

2. 放射科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to investigate the value of ultrasound microvessel imaging for evaluation of transplant kidney health. Magnetic ...

3. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

4. 血液科- 临床试验- 妙佑医疗国际

   However, the FDA has allowed the use of this drug in this research study. Testing Whether High Dose Chemotherapy And Infusion Of The Patients' Own Stem Cells ...

5. 血液科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn. The goal of this study is to provide access to brexucabtagene autoleucel for patients diagnosed with a disease approved for ...

6. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine whether administration of Topical Transexamic Acid (TXA) at the time of tissue expander placement in the setting ...

7. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and feasibility of surgical resection for pre-recurrent brain tumors. Eligible patients with surgically ...

8. 内分泌科- 临床试验- 妙佑医疗国际

   The purpose of this study is to establish incidence and prevalence of Impulse Control Disorders (ICDs) in patients with prolactinomas treated with dopamine ...

9. 外科 - 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn. The purpose of this study is to look at the effects cancer and melanoma have on the immune cells found in lymph nodes. A ...

10. 脑肿瘤项目- 临床试验- 妙佑医疗国际

    Eligibility Criteria, keep current Eligibility Criteria, but precede ... Also eligible are (11) up to 6 donors with triple negative breast cancer and ...